Nonnucleoside Reverse Transcriptase Inhibitor Pharmacokinetics in a Large Unselected Cohort of HIV-Infected Women (vol 50, pg 482, 2009)

被引：0
|
作者：
Gandhi
机构：
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2011年 / 58卷 / 04期
关键词：
D O I：
10.1097/QAI.0b013e31823e4ead
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E120 / E120
页数：1
相关论文
共 50 条
  • [1] Nonnucleoside Reverse Transcriptase Inhibitor Pharmacokinetics in a Large Unselected Cohort of HIV-Infected Women
    Gandhi, Monica
    Benet, Leslie Z.
    Bacchetti, Peter
    Kalinowski, Ann
    Anastos, Kathryn
    Wolfe, Alan R.
    Young, Mary
    Cohen, Mardge
    Minkoff, Howard
    Gange, Stephen J.
    Greenblatt, Ruth M.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 50 (05) : 482 - 491
  • [2] Pharmacokinetics of the nonnucleoside reverse transcriptase inhibitor efavirenz among HIV-infected Ugandans
    Nanzigu, S.
    Eriksen, J.
    Makumbi, F.
    Lanke, S.
    Mahindi, M.
    Kiguba, R.
    Beck, O.
    Ma, Q.
    Morse, G. D.
    Gustafsson, L. L.
    Waako, P.
    HIV MEDICINE, 2012, 13 (04) : 193 - 201
  • [3] Importance of nonnucleoside reverse transcriptase inhibitors on the pharmacokinetics of amprenavir and ritonavir in HIV-infected patients
    Choudey, N.
    Goujard, C.
    Meynard, J. L.
    Vincent, I.
    Demarles, D.
    Taburet, A. M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 66 - 66
  • [4] Pharmacokinetics of Lopinavir-Ritonavir with and without Nonnucleoside Reverse Transcriptase Inhibitors in Ugandan HIV-Infected Adults
    Kityo, C.
    Walker, A. S.
    Dickinson, L.
    Lutwama, F.
    Kayiwa, J.
    Ssali, F.
    Nalumenya, R.
    Tumukunde, D.
    Munderi, P.
    Reid, A.
    Gilks, C. F.
    Gibb, D. M.
    Khoo, S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (07) : 2965 - 2973
  • [5] Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected women
    Min, SS
    Corbett, AH
    Rezk, N
    Cu-Uvin, S
    Fiscus, SA
    Petch, L
    Cohen, MS
    Kashuba, ADM
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 37 (05) : 1577 - 1580
  • [6] Virologic and Immunologic Outcomes of HIV-Infected Ugandan Children Randomized to Lopinavir/Ritonavir or Nonnucleoside Reverse Transcriptase Inhibitor Therapy
    Ruel, Theodore D.
    Kakuru, Abel
    Ikilezi, Gloria
    Mwangwa, Florence
    Dorsey, Grant
    Rosenthal, Philip J.
    Charlebois, Edwin
    Havlir, Diane
    Kamya, Moses
    Achan, Jane
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 65 (05) : 535 - 541
  • [7] CYP2B6 Polymorphism and Nonnucleoside Reverse Transcriptase Inhibitor Plasma Concentrations in Chinese HIV-Infected Patients
    Chen, Jun
    Sun, Jianjun
    Ma, Qing
    Yao, Yaming
    Wang, Zhenyan
    Zhang, Lijun
    Li, Li
    Sun, Fuyan
    Lu, Hongzhou
    THERAPEUTIC DRUG MONITORING, 2010, 32 (05) : 573 - 578
  • [8] Triple nucleoside reverse transcriptase inhibitor- vs. nonnucleoside reverse transcriptase inhibitor-containing regimens as first-line therapy: efficacy and durability in a prospective cohort of French HIV-infected patients
    Cuzin, L
    Pugliese, P
    Bugnon, F
    Delpierre, C
    Cua, E
    Billaud, E
    Massip, P
    Raffi, F
    Dellamonica, P
    HIV MEDICINE, 2005, 6 (06) : 388 - 395
  • [9] Importance of reverse transcriptase inhibitors on the pharmacokinetics of amprenavir and ritonavir in HIV-infected patients
    Choudey, N.
    Goujard, C.
    Meynard, J. L.
    Vincent, I.
    Demarles, D.
    Taburet, A. M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 65 - 65
  • [10] Antiviral efficacy, tolerability and pharmacokinetics of efavirenz in an unselected cohort of HIV-infected children
    Wintergerst, U.
    Hoffmann, F.
    Jansson, A.
    Notheis, G.
    Huss, K.
    Kurowski, M.
    Burger, D.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (06) : 1336 - 1339
12345